Cellectar Biosciences, Inc. — Director's Dealing 2014

Sep 5, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2014-08-15

Reporting Person: Cormorant Asset Management, LLC (10% Owner)
Reporting Person: Chen Bihua (Director, 10% Owner)
Reporting Person: Cormorant Global Healthcare GP, LLC (10% Owner)
Reporting Person: Cormorant Global Healthcare Master Fund, LP (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	530000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants	$0.01	2019-08-20	Common Stock (530000)		Indirect

Footnotes

F1: The securities reported herein are held by Cormorant Global Healthcare Master Fund, LP (the "Fund"). Mr. Laughlin serves as manager of North Tide. Cormorant Global Healthcare GP, LLC (the "GP") serves as the general partner of the Fund, and Cormorant Asset Management, LLC (the "Manager") serves as the investment manager of the Fund. Bihua Chen serves as the managing member of the GP and the Manager. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 3 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.